What is ASRT's health score?

Assertio Holdings, Inc. (ASRT) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ASRT's estimated fair value?

Based on our 5-year discounted cash flow model, Assertio Holdings, Inc.'s estimated fair value is $194.86 per share, representing a 730.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ASRT undervalued or overvalued?

Our model currently rates ASRT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ASRT... Refresh in a moment for the full analysis.

Assertio Holdings, Inc. (ASRT)

Healthcare Undervalued low weak

$23.45

Updated: 2026-06-04

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

20 Stressed

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

50 Mixed

Est. Fair Value $194.86

DCF Upside +730.9%

Sector Rank #700 of 6677

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.